Alemtuzumab + Rituximab Consolidation in CLL
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)
- Status
- COMPLETED
- Phase
- PHASE1
Assess the Oral Bioavailability of New ABT-263 Formulations
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Status
- COMPLETED
- Phase
- PHASE2
8-Chloro-Adenosine in Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
- Status
- COMPLETED
- Phase
- PHASE2
T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL
- Status
- COMPLETED
- Phase
- PHASE1
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
- Status
- COMPLETED
- Phase
- PHASE2
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
- Status
- UNKNOWN
- Phase
- PHASE2
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE1